A longitudinal assessment of sleep architecture in children and adolescents with craniopharyngioma.

Association of GLP-1 Receptor Agonist Use with Hypersomnolence: A Real-world Cohort Analysis.

Patient-reported experiences of cognitive difficulties and their impact on daily life in narcolepsy type 1.

An updated systematic review and meta-analysis of modafinil for excessive daytime sleepiness in narcolepsy.

Effects of an orexin receptor 2-selective agonist on salivary secretion in rats.

Effectiveness and Safety of Low-Sodium Oxybate in Participants with Idiopathic Hypersomnia: Primary Results from the DUET Study.

Increased Numbers of CD4+ T-Cells in the Hypocretin/Orexin Region of Narcolepsy Type 1.

Narcolepsy type 1: an autoimmune disease.

Investigation of the "Not Better Explained" Diagnosis Criteria in Sleep Disorder Classifications: A Systematic Content Analysis and Critical Review.

Patient-reported outcome measures in central disorders of hypersomnolence: consensus of a sleep consortium/RARE-X expert working group.

Effectiveness of Stimulant Treatment in Preventing Fractures and Head Injuries in Patients With Narcolepsy: A Self-Controlled Case Series Study.

Mapping nocturnal arousal across sleep and pain disorders.

Test-retest repeatability of the multiple sleep latency test in non-cataleptic hypersomnolence disorders.

[Therapeutic potential of histamine N-methyltransferase inhibition for the treatment of hypersomnia].

Homeostatic dysregulation of slow wave activity during sleep in Idiopathic Hypersomnia.

Rare-variant burden across lysosomal genes implicates sialylation and ganglioside metabolism in Parkinson's disease.

Narcolepsy and metabolic disease: A meta-analytic synthesis.

Initial validation of a pediatric cataplexy survey for children and adolescents with narcolepsy type 1.

How sleeping minds decide: State-specific reconfigurations of lexical decision-making.

Samelisant (SUVN-G3031), a histamine H3 receptor inverse agonist, as a potential treatment for narcolepsy: a phase-2 drug evaluation.

Under-Recognition of Rapid Eye Movement Sleep Behavior Disorder in Younger Populations.

Disparities in Diagnosis of and Management of Narcolepsy and Idiopathic Hypersomnia.

Novel Cyclopentapyrrole Compounds as Orexin Receptor Agonists for Treating Sleep Disorders, namely, Narcolepsy and Hypersomnia.

Ghrelin's role in sleep and sleep deprivation: a narrative review.

Bioinformatics identification and experimental validation of hub genes associated with narcolepsy type 1.

Epidemiology and Economic Burden of Sleep Disorders in Europe.

Cataplexy-Like Episodes Following Suvorexant Use in a Non-Narcoleptic Patient: A Brief Report.

Clinical significance of ADHD traits in central disorders of hypersomnolence.

Idiopathic hypersomnia is a 24-hour disorder.

Clinical and polysomnographic changes in idiopathic hypersomnia ten years after the diagnosis.

Unravelling Narcolepsy: A Series of Complex Pediatric Cases.

Mazindol Immediate-Release/Sustained-Release (IR/SR): A 50-Year Legacy of Multifaceted Mechanisms and Emerging Therapeutic Potential.

iSPHYNCS: Unsupervised Clustering in Questionnaires and Metadata Reveals Distinct Subtypes in the Narcolepsy Borderland.

An Unusual Case of Hypersomnolence.

Incidence and prevalence of obstructive sleep apnoea and narcolepsy in the UK: a population-based descriptive study.

[Chinese expert consensus on the clinical application of wake-promoting agents].

Microbial-Immune Interplay in CNS Autoimmune Diseases: Lessons from Animal Models and Clinical Studies.

Perspectives on idiopathic hypersomnia: diagnostic challenges, unknown pathophysiological, and emerging therapeutic strategies.

Differential motor signatures in isolated and narcolepsy-related REM sleep behaviour disorder: a preliminary study.

Pitolisant-associated mania - a case report.

Skin thermal dynamics and hypothalamic thermosensitivity dissociate REM sleep and cataplexy in narcolepsy.

Interpreting the Study on Narcolepsy and Cardiovascular Outcomes: Expanding Clinical Perspectives.

High-resolution sleep fragmentation assessment in narcolepsy type 1 and their non-narcoleptic siblings: a 5-second mini-epoch study.

Glymphatic dysfunction and its association with clinical symptom severity in narcolepsy type 1: a case-control DTI-ALPS study.

A real-world study on the treatment of pediatric narcolepsy with pitolisant in China.

"A nano-enabled screen-printed paper-based electrochemical device with a 3D-printed wristband cassette design for selective and real-time detection of club drug amphetamine in complex matrices".

Sleep, wake, and signaling: Functional profiling of orexin agonists and antagonists using newly developed orexin β-arrestin 2 and miniGαq recruitment assays.

Disorder-specific alterations of transient oscillatory dynamics during sleep across cortical and subcortical networks.

Stiff Person Syndrome: A Case Report.

Clinical significance of nocturnal sleep onset REM periods in narcolepsy diagnosis and diagnostic stability.

Toward better subcategorization of narcolepsy type 2.

Delayed Emergence From Anesthesia After Esophagogastroduodenoscopy/Colonoscopy in an Adult Patient With Narcolepsy.

Sleep apnoea and its consequences: from animal models to precision medicine.

Secondary narcolepsy and cognitive dysfunction related to craniopharyngioma: a case study.

Intelligence quotient in adults with idiopathic hypersomnia and narcolepsy type 1.

Sleep neurology: pearls and pitfalls.

Circadian Variations in Cognitive Performance Among Patients With Narcolepsy and Obstructive Sleep Apnea: A Comparative Study.

Clinical and socioeconomic burden among people with narcolepsy or idiopathic hypersomnia: A retrospective cohort analysis of the Danish National Patient Registry.

Research Progress in the Roles of Influenza A H1N1 Virus and Its Vaccine in the Pathogenesis of Narcolepsy Type 1.

Orexin receptor 2 agonists: a pathophysiologic approach to narcolepsy type 1.

Circadian rest-activity rhythm in patients with narcolepsy following modafinil treatment: Outcomes and predictive markers.

Sleep Disorders and Nonalcoholic Fatty Liver Disease: Evidence From Meta-Analysis and Mendelian Randomization.

[Huntington's disease presenting with schizophreniform psychosis and narcolepsy in the premotor phase].

A case and review of fibroblast growth factor-23-mediated hypophosphatemic osteomalacia in the absence of pathogenic PHEX variants.

Narcolepsy Associated With Streptococcal Infection: A Case Report and Literature Review.

Clinical and instrumental comparison between insufficient sleep syndrome and narcolepsy type 1.

Sleep stage classification from ECG using machine learning: Evaluating the impact of signal duration.

Mass Spectrometry-Based Quantification of Orexin Species in Human Cerebrospinal Fluid Reveals Differential Dynamics Associated with Sleep.

Serum Metabolomic Signatures of Dyslipidemia in Narcolepsy Type 1: A Multi-Center Cross-Sectional Study.

Causality of blood metabolites and narcolepsy type 1: A Mendelian randomization study.

Histamine N-methyltransferase inhibition as a novel therapeutic strategy for idiopathic hypersomnia.

Bupropion for Treatment of Depression and Narcolepsy in a Postpartum Patient.

Neuroimaging findings in sleep disorders: A review article.

Lack of association between G6PD variants and Parkinson disease.

A Comprehensive Review of Current and Emerging Treatments for Narcolepsy Type 1.

Assessing Condition-Specific Adverse Event Profiles of Modafinil for Labelled and Off-Label Uses: A Systematic Review and Meta-Analysis.

HLA-DQB1*03:01 strongly affects age of onset of type 1 narcolepsy independently of DQA1 and ethnicity.

The Risks of Injury and Accident in Patients With Central Hypersomnia: A Cohort Study in Taiwan.

Effects of Oveporexton, an Orexin Receptor 2-Selective Agonist, on Cognition in Narcolepsy Type 1: A Secondary Analysis of a Randomized Clinical Trial.

Clinical pearls for the treatment of narcolepsy.

Narcolepsy: Pathophysiology, Diagnosis, Management, and Future Directions, a Narrative Review.

Tactile Hallucinations in Pediatric and Young Adults With Narcolepsy: A Case Series and Review of the Literature.

Classification and clustering on nocturnal polysomnography: distinctions and overlaps between central disorders of hypersomnolence.

Lack of epistatic interaction of SNCA with APOE in synucleinopathies.

Archetypal Analysis for the Characterization of Distinct Patterns in Mouse Sleep Data.

From Normal Variation in Sleep to Clinical Sleep Disorders: Genetic Insights from Over One Million Individuals.

Artificial intelligence and sleep medicine II: A scoping review of applications, advancements, and future directions.

Sleep disturbances in craniopharyngioma: a systematic review and meta-analysis.

Efficacy and Safety of Pitolisant for Excessive Daytime Sleepiness in Narcolepsy and Obstructive Sleep Apnea: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.

'It's hard to feel this way every single day': patients' perspectives on the emotional burden of narcolepsy.

Cannabis Use in Central Disorders of Hypersomnolence in the Netherlands.

Sleep time and SOREMPs features support idiopathic hypersomnia and narcolepsy type 2 as a single disease entity.

Animal Models of Narcolepsy: From Orexin Deficiency to Immune Mechanisms and Regenerative Therapies.

Tablet-Assisted Speech and Language Therapy for Acute Post-Stroke Aphasia: A Randomized Clinical Trial (LEXI Study).

Risk of neurologic or immune-mediated adverse events after COVID-19 diagnosis in the United States.

The incidence, prevalence and treatment of narcolepsy in New Zealand.

Development of Novel 18F‑Labeled Selective Orexin‑2 Receptor Radioligands for Positron Emission Tomography.

Very late-onset narcolepsy type 1: diagnosis in the ninth decade.

"My Partner Just Wants to Sleep": A Qualitative Study of the Experience of Living with a Partner with Narcolepsy or Idiopathic Hypersomnia.

Hypothalamic functional connectivity, depressive symptoms, and post-treatment SOREMPs in narcolepsy type 1: links to sleep latency and mediation mechanisms.

Comparative efficacy of new wake-promoting agents for narcolepsy-a network meta-analysis.

Altered Sleep Patterns in Wilson's Disease Including Shortened REM Latency.

A new decision-making approach for residual excessive daytime sleepiness in patients treated for OSAHS: the Blob-Algorithm proposition.

Association between lipopolysaccharide-binding protein levels and disease severity in pediatric narcolepsy: A cross-sectional study.

Circadian Modulation of Sleep-Wake Behavior in Patients with Narcolepsy Type 1 and Idiopathic Hypersomnia.

Prolintane analogs as hybrid monoamine transporter ligands: Structural determinants and species differences.

Impact of neuromodulation on excessive daytime sleepiness: a narrative review.

Attention and inhibition deficits in narcolepsy type 1: behavioral and electrophysiological markers.

Co-morbid monogenic disorders at chromosome region 1q2: LMNA- and FLG-related disorders in a patient referred for assessment of joint hypermobility.

Sleep Disorders, Dysregulation of Circadian Rhythms, and Fatigue After Craniopharyngioma-A Narrative Review.

Guidelines From the French-Speaking Society for Histocompatibility and Immunogenetics (SFHI) for Harmonisation of HLA Genotyping in Autoimmune Diseases, Drug Hypersensitivity and Pharmacogenetics.

Mortality Risk Study Offers Good News for Patients With Narcolepsy.

The impact of sleep disturbance on post-transplant recovery and quality of life: Neural mechanisms and translational management strategies.

[Symptomatic Narcolepsy due to Neurological Disorders].

[Pathophysiology of Narcolepsy].

[Autoimmune Encephalitis and Associated Sleep Disorders].

[Neural Circuit Mechanisms Underlying REM Sleep].

Effects of High- Versus Low-Sodium Oxybate on Blood Pressure in Patients With Narcolepsy.

Sleep disturbances in brain tumors: a narrative review.

Assessing sleep disorders in neuromyelitis optica spectrum disorder: A comparison of qualitative and quantitative approaches.

Orexin Deficiency in Narcolepsy: Molecular Mechanisms, Clinical Phenotypes, and Emerging Therapeutic Frontiers.

All-Cause and Cause-Specific Mortality Among Patients With Narcolepsy.

Stridor Is an Independent Risk Factor for Mortality and Disease Progression in Patients with Multiple System Atrophy.

Improving Daytime Sleepiness in Children and Adolescents With Narcolepsy: A Quality Improvement Initiative.

Challenges and methodological considerations for research on the role of sleep stage transitions in altered affective processing.

Using Real-time Reporting to Investigate Visual Experiences in Dreams.

Underestimation of nocturnal sleep duration in central disorders of hypersomnolence: an underrecognized feature?

Orexin 1-16 as the stable metabolite behind low CSF orexin/hypocretin immunoreactivity in narcolepsy.

Pharmacovigilance Insights into Ibuprofen's Neuropsychiatric Safety: A Retrospective Analysis of EudraVigilance Reports.

The role of orexin and MCH neurons in the hypothalamus in sleep-wake regulation and learning-forgetting balance.

Association between cytokines and neuropsychiatric symptoms in paediatric narcolepsy patients: a cross-sectional study.

Understanding idiopathic hypersomnia: diagnosis, pathophysiology, and management.

How golden age Arab-Islamic scholars revolutionized sleep physiology and dream analysis.

Dynamic Functional Network Connectivity Patterns Distinguish Neurobiological Substrates of Narcolepsy Type 1 and Idiopathic Hypersomnia: Potential Biomarkers From Resting-State fMRI.

Physical activity: a safe step toward better quality of life in narcolepsy.

Post-marketing safety of solriamfetol: A retrospective pharmacovigilance study based on the us food and drug administration adverse event reporting system.

Central disorders of hypersomnolence - A narrative review on current and potential biomarkers.

DNA methylation and multi-omics profiling of T cells uncovers chemotactic pathways and proliferation-linked hypomethylation in narcolepsy type 1.

Post-traumatic stress disorder and REM-sleep behavior disorder: exploring genetic associations and causal links.

Phasic events, cyclic alternating pattern (CAP) and sleep disorders.

Solriamfetol improves daily fatigue symptoms in adults with myalgic encephalomyelitis/chronic fatigue syndrome after 8 weeks of treatment.

Hummingbird sign in a patient with DNMT1-related disorder.

Feasibility and efficacy of exercise training on sleep symptoms and comorbidities in narcolepsy type 1: a prospective interventional study.

Hypocretin: a promising target for the regulation of homeostasis.

REM Density, Leg Movements, and REM Sleep without Atonia: Differentiating Type 1 from Type 2 Narcolepsy Through Polysomnographic Analysis, a Preliminary Study.

Sleep Paralysis: Pathogenesis, Clinical Manifestations, and Treatment Strategies.

Dissolution of Once-Nightly Sodium Oxybate in Soft Foods and Alternative Liquid Reconstitution Vehicles.

Prevalence and Factors Associated with Rapid Eye Movement-Related Obstructive Sleep Apnea in Patients with Narcolepsy.

A comprehensive study on drug-related Raynaud's phenomenon based on the FDA adverse event reporting system.

Unique Polysomnography Pattern Leading to the Diagnosis of Anti-Ma2 Encephalitis.

Localized and historical hypermobile spectrum disorders share self-reported symptoms and comorbidities with hEDS and HSD.

Quantification of electromyographic activity during REM sleep in Chinese narcolepsy patients and healthy controls: a comparative study.

Decoding ligand recognition and constitutive activation of histamine H3 and H4 receptors.

Narcolepsy 2025 (with an Australasian perspective).

Facial Emotion Recognition in Children With Narcolepsy Type 1.

Transforming sleep medicine: the evolving role of artificial intelligence.

Once-Nightly Sodium Oxybate Meets American Academy of Sleep Medicine Criteria for Treatment of Narcolepsy.

Beyond neuronal loss: epigenetic signatures bridging immune activation and sleep dysfunction in narcolepsy type 1.

Hypocretin/orexin peptide release occurs mostly extrasynaptically, is self-controlled, and specifically enhanced in female rats.

Usefulness of the adult concentration inventory in the psychological assessment of adult sleep disorder patients.

The impacts of sleep loss on wake-active neurons.

Selective modulation of orexinergic receptors by neem-derived phytochemicals: Computational analysis of structure-activity relationships.

Narcolepsy and risk of cardiovascular outcomes: getting to the heart of the matter.

Initial experience and establishment of a hypersomnia board: A multidisciplinary approach to complex hypersomnia cases.

Age at Onset and Delays in Diagnosis of Central Disorders of Hypersomnolence Over the Past 30 Years.

Restless Legs Syndrome, Periodic Leg Movements, Hypertension and Cardiovascular Diseases.

Narcolepsy type 2 is an unstable diagnosis and idiopathic hypersomnia has the potential for remission-long-term and cross-sectional observations from the Bern Sleep-Wake Registry.

Molecular Pathways Potentially Involved in Hallucinatory Experiences During Sleep Paralysis: The Emerging Role of β-Arrestin-2.

16-mer hypocretin-1/orexin-A in cerebrospinal fluid to diagnose narcolepsy.

The Clinical and Economic Burden of Idiopathic Hypersomnia and Narcolepsy: A United States Claims-Based Analysis.

Neuroinflammation distinguishes HLA haplotypes in progressive supranuclear palsy.

Beyond Pediatric Sleep Disorders: A Case of Hypersomnia Revealing Hashimoto's Encephalopathy.

Leading orexin receptor agonist clears phase III for narcolepsy.

Telomere length in sleep disorders.

Orexin effect on physiological pulsations of the human brain.

Research progress in sleep disorders associated with multiple sclerosis.

Quality measures for care of patients with narcolepsy: 2025 update after measure maintenance.

Driving Safety among Adolescents with Health Conditions: An Integrative Review.

A Permutation Entropy Method for Sleep Disorder Screening.

Depressive symptoms and suicidal thoughts in idiopathic hypersomnia: a cross-sectional and longitudinal study.

Corticotropin-Releasing Hormone (CRH) in Murine Narcolepsy: What Do Genetic and Immune Models Tell Us?

Artificial Intelligence Chatbots and Narcolepsy: Friend or Foe for Patient Information?

The inter-night variability of REM sleep without atonia in adult patients with central disorders of hypersomnolence.

Current insights into the safety and adverse effects of methylphenidate in children, adolescents, and adults - narrative review.

Corrigendum to "Factors associated with diagnostic delay in narcolepsy: Real-world data from a Korean multicenter study" [Sleep Med 133 (2025) 106646].

Management of Insomnia Complaints by Non-Sleep Specialist Physicians: A French DELPHI Consensus.

Green spectrofluorimetric method for quantification of sodium oxybate in pharmaceutical and plasma samples.

Integrative evidence linking excessive daytime sleepiness, narcolepsy, and hypertension: insights from NHANES, Mendelian randomization, and proteomics.

Discovery of natural orexin 2 receptor antagonists from Valeriana species: A potential approach for insomnia treatment.

Evaluating the safety of XBB.1.5-containing COVID-19 mRNA vaccines using a self-controlled case series study.

Relationship between sleep characteristics and aortic aneurysm/dissection: a two-sample Mendelian randomisation study.

Narcolepsy and risk of cardiovascular outcomes beyond stimulant use.

Molecular Insights into the Interaction of Orexin 1 Receptor Antagonists: A Comprehensive Study Using Classical and Quantum Computational Methods.

Narcolepsy: a machine learning bibliometric analysis (1996-2024).

Abnormal brain functional network dynamics in narcolepsy type 1 patients.

A path analysis of factors influencing life satisfaction among patients with narcolepsy in Japan.

Non-obstructive sleep apnea pediatric sleep disorders: what the otolaryngologist should know.

The burden of narcolepsy symptoms from patients' perspective: a narrative qualitative study.